In the subcutaneous xenograft mouse model, knockdown of DCAF7 significantly enhanced cisplatin sensitivity, leading to reduced tumor size and weight in cisplatin‐treated mice (Figure 2A–C). The gene discussed is DCAF7; the disease is neoplasm.